TY  - GEN
AU  - Reinmuth,N
AU  - Heigener,D
AU  - Goldmann,T
AU  - Watermann,I
AU  - Reck,M
TI  - [A reduced TKI dosage is not associated with loss of activity in EGFR mutated NSCLC patients]
SN  - 1438-8790
PY  - 2015///1015
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - diagnosis
KW  - Dose-Response Relationship, Drug
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Mutation
KW  - genetics
KW  - Polymorphism, Single Nucleotide
KW  - Protein Kinase Inhibitors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1055/s-0034-1377927
ER  -